AbbVie Inc. isn't saying much about its plans for Cerevel Therapeutics Inc. after announcing it would acquire the neuroscience firm for nearly $9 billion.
AbbVie Inc. isn't saying much about its plans for Cerevel Therapeutics Inc. after announcing it would acquire the neuroscience firm for nearly $9 billion.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.